News

Eli Lilly and Company (NYSE: LLY) is one of the best Fortune 500 stocks to buy according to billionaires. On June 20, Eli ...
‘Lost’ Actress Abruptly Cancels Festival Appearance After Serious Fall originally appeared on Parade. Evangeline Lilly ...
Eli Lilly's experimental obesity therapy bimagrumab drew mixed reactions from Wall Street after the company recently ...
Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as ...
At this year’s Morningstar Investment Conference in Chicago, Morningstar equity researchers will share their insights on the ...
Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal antibody that binds to and inhibits activin receptor type-2B, with semaglutide ...
Regeneron shows financial strength and fair valuation, but trevogrumab's Phase 2 progress adds uncertainty. Click here to ...
Glenmark Pharmaceuticals on Tuesday said it has launched the lung cancer treatment drug Tevimbra in India, following the ...
Novo Nordisk launches weightloss drug Wegovy in India at competitive prices, facing patent battles and high demand.
Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is ...
Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.
In this video, Susana M. Campos, MD, MPH, discusses new research on adding metformin to letrozole/abemaciclib for the treatment of estrogen receptor-positive, recurrent endometrial cancer.The data ...